Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Chronic Venous Occlusions Treatment Market Growth Potential: How Will Market Size Change Through 2030?
The market for treating chronic venous occlusions has experienced robust expansion historically, projecting a rise from $7.15 billion in 2025 to $7.6 billion by 2026, reflecting a compound annual growth rate of 6.3%. This recent surge can be attributed to several key factors including the increasing incidence of venous disorders, a greater accessibility to endovascular treatment methods, an uptick in hospital-based interventional procedures, heightened public and professional awareness of chronic venous diseases, and the broader application of anticoagulant therapies.
The market for treating chronic venous occlusions is poised for substantial expansion in the upcoming years, projected to reach $10.08 billion by 2030, exhibiting a compound annual growth rate of 7.3%. This anticipated growth over the forecast period is fueled by several key factors, including a demographic shift towards an older population, escalating demand for outpatient procedures addressing venous conditions, a heightened emphasis on early disease detection, the proliferation of advanced imaging techniques aiding treatment, and a greater uptake of next-generation venous devices. Significant trends shaping this market’s trajectory include a rising inclination towards less invasive venous interventions, increased utilization of sophisticated venous stenting technologies, a growing preference for integrated therapeutic approaches combining devices and pharmaceuticals, the broader application of image-guided endovascular procedures, and a reinforced focus on managing occlusions over the long term.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13286&type=smp
Chronic Venous Occlusions Treatment Market Opportunity Drivers: What Is Creating New Revenue Potential?
The escalating prevalence of obesity is poised to be a significant catalyst for the expansion of the chronic venous occlusion treatment market. Obesity, defined as an unhealthy buildup of body fat leading to a BMI of 30 or more, presents complications that chronic venous occlusion treatments can address. By enhancing circulatory function and mitigating inflammatory responses, these treatments can effectively manage obesity-related issues such as swelling and skin afflictions, thereby facilitating better overall weight management. Illustrating this trend, in March 2023, the World Heart Federation reported that approximately 2.3 billion adults and children worldwide were classified as obese or overweight, with projections indicating this figure could climb to 2.7 billion by 2025 if current trends persist. Consequently, the increasing number of individuals affected by obesity directly fuels the market demand for chronic venous occlusion treatments.
Chronic Venous Occlusions Treatment Market Segment Outlook: Which Categories Are Expanding The Fastest?
The chronic venous occlusions treatment market covered in this report is segmented –
1) By Product: Devices, Drugs
2) By Application: Varicose Veins, Venous Stasis Ulcers, Edema, Deep Vein Thrombosis, Other Applications
3) By End User: Hospitals, Clinics, Ambulatory Surgery Centers, Trauma centers, Other End-Users
Subsegments:
1) By Devices: Venous Stents, Catheters, Endovenous Laser Therapy (EVLT) Devices, Angioplasty Balloons
2) By Drugs: Anticoagulants, Thrombolytics, Anti-inflammatory Medications, Pain Management Drugs
Chronic Venous Occlusions Treatment Market Innovation Trends Driving Future Development
Leading entities within the chronic venous occlusion therapeutics sector are prioritizing the creation of novel approaches, exemplified by implantable medical apparatus designed to address the symptomatic impediments to venous blood flow experienced by individuals suffering from chronic venous insufficiency. These surgically inserted devices are intended for long-term residence within the body, serving purposes of diagnosis, treatment, or ongoing health monitoring. A relevant illustration from June 2024 is the introduction of the Duo Venous Stent System, an implantable medical device brought to market by the Dutch technology firm Koninklijke Philips N.V. This particular system from Koninklijke Philips N.V. distinguishes itself with a bifold architecture that concurrently boosts suppleness and circumferential resilience, thereby providing superior support to the affected veins. Furthermore, its sophisticated surface treatment contributes to improved biological compatibility and a reduced likelihood of clot formation, complemented by a meticulously engineered deployment mechanism that guarantees exact positioning even in complex anatomical scenarios.
Chronic Venous Occlusions Treatment Market Key Companies And Competitive Benchmarking
Major companies operating in the chronic venous occlusions treatment market are Cardinal Health Inc., Bayer AG, Sanofi S.A., 3M Company, Bristol-Myers Squibb Company, Medtronic PLC, Becton, Dickinson and Company (BD), Stryker Corporation, Boston Scientific Corporation, Terumo Corporation, Ethicon Inc., Philips Medical Systems, Teleflex Incorporated, Cook Group Incorporated, Merit Medical Systems Inc., Integer Holdings Corporation, Penumbra Inc., Inari Medical, Argon Medical Devices Inc., AngioDynamics Inc., Rontis Corporation, Endologix, Richard Wolf GmbH, SIGVARIS AG, enVVeno Medical Corporation, LimFlow SA
Access The Complete Chronic Venous Occlusions Treatment Market Report:
Chronic Venous Occlusions Treatment Market Leading Geography: Which Region Generates The Most Revenue?
North Americawas the largest region in the chronic venous occlusions treatment market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the chronic venous occlusions treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
